TELA Bio (TELA) Operating Expenses (2018 - 2026)

TELA Bio's Operating Expenses history runs 9 years deep, the most recent figure standing at $23.0 million for Q1 2026.

• On a quarterly basis, Operating Expenses changed 0.27% year-over-year to $23.0 million in Q1 2026; TTM through Mar 2026 was $88.2 million, a 0.84% increase from a year earlier, with the FY2025 full-year figure at $88.1 million, changed 0.1% from the prior year.
• Operating Expenses climbed to $23.0 million in Q1 2026 per TELA's latest filing, from $20.4 million in the prior quarter.
• Across five years, Operating Expenses topped out at $23.9 million in Q4 2023 and bottomed at $14.8 million in Q1 2022.
• The 5-year median for Operating Expenses is $20.6 million (2023), against an average of $20.6 million.
• Across the five-year window, Operating Expenses surged 42.19% in 2022 and slipped 18.1% in 2024, its largest moves.
• Year by year, Operating Expenses stood at $17.6 million in 2022, then soared by 35.69% to $23.9 million in 2023, then declined by 18.1% to $19.6 million in 2024, then climbed by 4.23% to $20.4 million in 2025, then gained by 12.95% to $23.0 million in 2026.
• Per Business Quant, the three latest TELA Operating Expenses figures stand at $23.0 million (Q1 2026), $20.4 million (Q4 2025), and $21.5 million (Q3 2025).